Today’s Zacks Research Daily highlights new reports on major stocks, including Apple Inc. (AAPL), Eli Lilly and Co. (LLY), and Visa Inc. (V). Apple’s strong growth in Services revenues and subscriber base are positives, but regulatory headwinds and tariffs pose risks. Eli Lilly’s key drugs continue to drive sales growth, while Visa’s strong market position and focus on digital payments are favorable.

Apple expects mid to high single-digit net sales growth in the fourth quarter with Services growth similar to the previous quarter. Eli Lilly’s new drugs contribute to top-line growth, but headwinds like declining sales of Trulicity remain a concern. Visa’s expansion in cross-border volumes and investments in AI and stablecoin infrastructure enhance its future prospects.

Other notable reports today include Merck & Co., Inc. (MRK), TotalEnergies SE (TTE), and Automatic Data Processing, Inc. (ADP). Merck’s Keytruda and new products are driving sales growth, while TotalEnergies’ presence in LNG and clean energy assets boosts performance. ADP’s transformation initiatives are positive, but rising expenses remain a concern.

In the world of quantum computing, Senior Stock Strategist Kevin Cook reveals 7 stocks poised to dominate the landscape, offering investors a chance to position their portfolios for this technological revolution. For more insights and recommendations, visit Zacks Investment Research.

Read more at Nasdaq: Top Stock Reports for Apple, Eli Lilly & Visa